Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Cervical Cancer

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 56 articles:
HTML format

Single Articles

    October 2021
    Study shows a decrease in cervical cancer but a rise in other human papillomavirus-related cancers.
    Cancer. 2021;127:3499.

    August 2021
  2. LIN S, Gao K, Gu S, You L, et al
    Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years.
    Cancer. 2021 Aug 9. doi: 10.1002/cncr.33795.
    PubMed     Abstract available

    July 2021
  3. MIX JM, Saraiya M, Thompson TD, Querec TD, et al
    Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States.
    Cancer. 2021 Jul 21. doi: 10.1002/cncr.33582.
    PubMed     Abstract available

    May 2021
  4. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
    Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
    PubMed     Abstract available

    April 2021
    Lower Cervical Cancer Risk Associated With HPV Vaccine.
    Cancer. 2021;127:1171.

  6. TAIT SD, Ren Y, Horton CC, Oshima SM, et al
    Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program: A retrospective review of 90,000 women.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33473.
    PubMed     Abstract available

    September 2020
  7. DUSKA LR, Scalici JM, Temkin SM, Schwarz JK, et al
    Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
    Cancer. 2020 Sep 10. doi: 10.1002/cncr.33136.
    PubMed     Abstract available

  8. DESSOURCES K, Hari A, Pineda E, Amneus MW, et al
    Socially determined cervical cancer care navigation: An effective step toward health care equity and care optimization.
    Cancer. 2020 Sep 5. doi: 10.1002/cncr.33124.
    PubMed     Abstract available

    August 2020
  9. GATTI A, Haruyama R, Elit L, Howard SC, et al
    How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33116.
    PubMed     Abstract available

  10. PRINTZ C
    Experts say that cervical cancer could be eliminated worldwide with screening, human papillomavirus vaccine.
    Cancer. 2020;126:3387.

    July 2020
  11. SRIVASTAVA AJ, Contreras JA, Davis M, Markovina ST, et al
    Early posttherapy clearance of human papillomavirus and treatment response in cervical carcinoma.
    Cancer. 2020 Jul 8. doi: 10.1002/cncr.33040.
    PubMed     Abstract available

    April 2020
  12. RODRIGUEZ AM, Zeybek B, Vaughn M, Westra J, et al
    Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Cancer. 2020;126:1656-1667.
    PubMed     Abstract available

    March 2020
  13. SALCEDO MP, Sood AK, Jhingran A, Eifel PJ, et al
    Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
    Cancer. 2020 Mar 3. doi: 10.1002/cncr.32807.
    PubMed     Abstract available

    February 2020
  14. PRINTZ C
    Low-income, Asian American women benefit from human papillomavirus self-sampling tests.
    Cancer. 2020;126:469.

    January 2020
  15. PRINTZ C
    Psychological stress is associated with a higher risk of cervical cancer mortality.
    Cancer. 2020;126:240-241.

    November 2019
  16. HUNG P, Deng S, Zahnd WE, Adams SA, et al
    Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
    Cancer. 2019 Nov 8. doi: 10.1002/cncr.32594.
    PubMed     Abstract available

    October 2019
  17. PRINTZ C
    Rethinking a common surgery technique for early cervical cancer: Experts are reconsidering the use of minimally invasive radical hysterectomy as a treatment for early cervical cancer after multiple studies found that patients who undergo the procedure
    Cancer. 2019;125:3485-3487.

  18. PRINTZ C
    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.

    September 2019
  19. FICHT AL, Lapidos-Salaiz I, Phelps BR
    Eliminating cervical cancer: Promising developments in primary prevention.
    Cancer. 2019 Sep 26. doi: 10.1002/cncr.32507.

    July 2019
  20. PRINTZ C
    HPV infections most often linked to cervical cancer have declined.
    Cancer. 2019;125:2336-2337.

    May 2019
  21. PRINTZ C
    Cervical cancer self-sampling tests could improve access.
    Cancer. 2019;125:1583.

    February 2019
  22. GROVER S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, et al
    HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
    Cancer. 2019 Feb 25. doi: 10.1002/cncr.31972.
    PubMed     Abstract available

    January 2019
  23. FROBERG M, Ostensson E, Belkic K, Ostrbenk A, et al
    Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Cancer. 2019;125:239-248.
    PubMed     Abstract available

    December 2018
  24. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.

    November 2018
  25. MAILHOT VEGA RB, Balogun OD, Ishaq OF, Bray F, et al
    Estimating child mortality associated with maternal mortality from breast and cervical cancer.
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31780.
    PubMed     Abstract available

    October 2018
  26. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    PubMed     Abstract available

    January 2018
  27. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Abstract available

    December 2017
  28. BENARD VB, Watson M, Saraiya M, Harewood R, et al
    Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5119-5137.
    PubMed     Abstract available

  29. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
    Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
    PubMed     Abstract available

    October 2017
  30. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Abstract available

  31. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Abstract available

    September 2017
  32. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    PubMed     Abstract available

    August 2017
  33. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    PubMed     Abstract available

    July 2017
  34. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.

  35. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Abstract available

    June 2017
  36. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Abstract available

    May 2017
  37. KOROUKIAN SM, Bakaki PM, Htoo PT, Han X, et al
    The Breast and Cervical Cancer Early Detection Program, Medicaid, and breast cancer outcomes among Ohio's underserved women.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30720.
    PubMed     Abstract available

  38. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Abstract available

  39. SMALL W JR, Bacon MA, Bajaj A, Chuang LT, et al
    Cervical cancer: A global health crisis.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30667.
    PubMed     Abstract available

    April 2017
  40. ALSBEIH GA, Al-Harbi NM, Bin Judia SS, Khoja HA, et al
    Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Cancer. 2017 Apr 10. doi: 10.1002/cncr.30635.
    PubMed     Abstract available

    March 2017
  41. BERMAN TA, Schiller JT
    Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30588.
    PubMed     Abstract available

  42. BENEVOLO M, Allia E, Gustinucci D, Rollo F, et al
    Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.
    Cancer. 2017;125:212-220.
    PubMed     Abstract available

    January 2017
  43. BRAR H, Hogen L, Covens A
    Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30509.
    PubMed     Abstract available

  44. BEAVIS AL, Gravitt PE, Rositch AF
    Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30507.
    PubMed     Abstract available

  45. DALTON HJ, Farley JH
    Racial disparities in cervical cancer: Worse than we thought.
    Cancer. 2017 Jan 23. doi: 10.1002/cncr.30501.

    December 2016
  46. OVESTAD IT, Dalen I, Hansen E, Loge JL, et al
    Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Cancer. 2016 Dec 5. doi: 10.1002/cncy.21807.
    PubMed     Abstract available

    November 2016
  47. FANG CY, Ma GX, Handorf EA, Feng Z, et al
    Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention.
    Cancer. 2016 Nov 21. doi: 10.1002/cncr.30391.
    PubMed     Abstract available

    October 2016
  48. THOMPSON B, Carosso EA, Jhingan E, Wang L, et al
    Results of a randomized controlled trial to increase cervical cancer screening among rural Latinas.
    Cancer. 2016 Oct 27. doi: 10.1002/cncr.30399.
    PubMed     Abstract available

  49. PATADJI S, Li Z, Pradhan D, Zhao C, et al
    Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Cancer. 2016 Oct 24. doi: 10.1002/cncy.21791.
    PubMed     Abstract available

  50. DOXTADER EE, Brainard JA, Underwood D, Chute DJ, et al
    Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Cancer. 2016 Oct 12. doi: 10.1002/cncy.21783.
    PubMed     Abstract available

  51. LI Y, Zeng J, Huang M, An J, et al
    A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma.
    Cancer. 2016 Oct 3. doi: 10.1002/cncr.30328.
    PubMed     Abstract available

    September 2016
  52. SILVER MI, Schiffman M, Fetterman B, Poitras NE, et al
    The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30277.
    PubMed     Abstract available

  53. HUH WK, Andrews JC
    Cervical cancer screening: How do we make sense of it all and what is the right balance?
    Cancer. 2016 Sep 22. doi: 10.1002/cncr.30276.

    May 2016
  54. WHOP LJ, Garvey G, Baade P, Cunningham J, et al
    The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000-2011).
    Cancer. 2016;122:1560-9.
    PubMed     Abstract available

  55. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Abstract available

    February 2016
  56. ARMSTRONG K, Kim JJ, Halm EA, Ballard RM, et al
    Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.
    Cancer. 2016 Feb 29. doi: 10.1002/cncr.29937.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.